Navigation Links
Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug

Cancer chemotherapy is not effective in treating cancer efficiently due to its non-specificity and inability to target the cancer cells alone. Due to this non-specificity there is increased // development of drug resistance shown by these cancer cells.

Normal cells and cancer cells depend on blood supply for sustenance and oxygen. Cutting off blood supply could be one way to kill the cancer cells. This is however fraught with problems as cancer cells have a propensity to create new blood vessels. Anti-angiogenesis drug prevents formation of development of new blood vessels. This process of cutting off blood supply is called anti-angiogenesis.

Combining the two methods — chemotherapy and anti-angiogenesis — can be another way to kill cancer cells. This has it own limitations though — drugs that cut off blood supply not only deprive cancer cells of oxygen but also chemotherapy drugs that can kill the cancer cells.

`Nanocells' (of 200 nanometres in size) in a balloon within a balloon design — to deliver chemotherapy agents and drugs for destroying the blood supply to the cancer cells. The outer balloon has the anti-angiogenesis agent and the inner balloon has chemotherapy drugs.

"We tried the other combination but it will not work out," Dr. Sasisekharan explained. "First you need a vascular shut down (blood supply cut off) and then release the chemotherapy drug.”This will not only increase the therapeutic index but also decrease the toxicity. And this will happen only if the outer balloon is filled with an anti-angiogenesis drug."

The ability of the `nanocells' to wreak complete destruction of cancerous cells is aided by the cancerous cells themselves. "Tumour vessels suck things into their environment and the nanocells get trapped in the tumour bed due to their large size," he elucidated. The size of the nanocell plays a crucial role. While the 200 nanometre size of the nanocell prevents it from coming out of the blood
'"/>




Page: 1 2

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Want skin cancer? Please have a cigarette
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Clintons new problem - Is the outgoing American president suffering from skin cancer?
5. Are cancer patients being taken for a ride?
6. Breast cancer treatment to be determined by gene test
7. Ductal lavage may detect early breast cancer
8. Beware of the oral patch! It could be cancer!!!
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ies, those called up to risk their lives in the se...d even ill-treated. Apparently the US is no except... their grievances during a hearing of the Presiden...l at Washington on Saturday. Speaking from exper...
...euticals Incorporated, a global biotechnology comp...rial on new hepatitis C drug, telaprevir. The drug...t has been shown. The planned interim results of ...nnounced at Barcelona on Saturday at the 42nd Annu...
...ted pessimism hangs thickly over Britain’s junior ...th since UK’s young doctors took the street in pro...te of most of them having dished out thousands of ... that would make them eligible for NHS employment....
...ts at Bonn University have created a software syst...l implants significantly. //With the aid of the so... exactly those signals, which are expected and can...two dozens of patients in Germany and the U.S. hav...
Other Medicine News:Health News:Military Healthcare Lacks Compassion, Say US Soldiers 2Health News:New Hepatitis C Drug Shows Promise 2Health News:UK’s Junior Doctors Losing Hop 2Health News:Software System to Improve the Function of Retinal Implants 2Health News:Software System to Improve the Function of Retinal Implants 3
(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008)...taq(R) (dronedarone) decreased the risk of,stroke ...al flutter already adequately treated...pt. 3 /- The results of a,p... were presented today at,the clinical trial update...gress 2008, in Munich, Germany. Previous results f...
(Date:9/3/2008)...s Strong Evidence Pycnogenol(R) Lowers Joint, Pain...Following Cessation of... -- According to the Center for,Disease Control (C...itis,is on the rise. A new study published in the...Pycnogenol(R), bark extract from the French mariti...
(Date:9/2/2008)...re-FirstCall/ -- Forest Laboratories, Inc.,(NYSE: ...nced results from,two global Phase III studies of ...ticholinergic for the treatment of patients with c...th the ACCLAIM/COPD I&II,(AClidinium CLinical Tria...ere COPD Patients) studies, once-daily aclidinium ...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 1AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 2AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove Illinois 1239 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 1Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 2Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 3Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Direct 1236 4Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 1Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 2Microtek Medical Receives Early Termination of Hart Scott Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab 1233 3Spiritual Healer Psychic Medium Reaches International Status 21 1230 1Spiritual Healer Psychic Medium Reaches International Status 21 1230 2
... Nasalfent shows clinically meaningful pain relief..., READING, England, 7 June 2007 - Archimedes Pharm...eutical company, today,presented new clinical data...ive fentanyl citrate nasal spray aimed at providin...reakthrough cancer,pain. Data were presented at th...
...Orexigen(TM) is evaluating zonisamide SR as a nove..., SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ ...utical company focused on the,treatment of central... obesity, today announced results from a Phase I t... novel, proprietary,sustained-release (SR) formul...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
The MediLive ImageBox is the first, easy-to-use digital,recording device that integrates with the surgical microscope and video camera., ,It simplifies image capturing by burning the still imag
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one.
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
...er Monitoring System, equipped with the latest Epi...is algorithm, Heart Rate Variability analysis and ...ith an Epicardia System in place have complete con...t their needs, and managing their data. The Epicar...
Medicine Products: